Chapman Paul W.d. - Net Worth and Insider Trading
Chapman Paul W.d. Net Worth
The estimated net worth of Chapman Paul W.d. is at least $15 dollars as of 2024-11-13. Chapman Paul W.d. is the COO of Millendo Therapeutics Inc and owns about 14 shares of Millendo Therapeutics Inc (MLND) stock worth over $15. Details can be seen in Chapman Paul W.d.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chapman Paul W.d. has not made any transactions after 2016-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chapman Paul W.d.
Chapman Paul W.d. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chapman Paul W.d. owns 2 companies in total, including Millendo Therapeutics Inc (MLND) , and Tempest Therapeutics Inc (TPST) .
Click here to see the complete history of Chapman Paul W.d.’s form 4 insider trades.
Insider Ownership Summary of Chapman Paul W.d.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MLND | Millendo Therapeutics Inc | 2016-05-10 | Chief Operating Officer |
| TPST | Tempest Therapeutics Inc | 2016-03-03 | Chief Operating Officer |
Chapman Paul W.d. Latest Holdings Summary
Chapman Paul W.d. currently owns a total of 1 stock. Chapman Paul W.d. owns 14 shares of Millendo Therapeutics Inc (MLND) as of May 10, 2016, with a value of $15.
Latest Holdings of Chapman Paul W.d.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MLND | Millendo Therapeutics Inc | 2016-05-10 | 14 | 1.06 | 15 |
Holding Weightings of Chapman Paul W.d.
Chapman Paul W.d. Form 4 Trading Tracker
According to the SEC Form 4 filings, Chapman Paul W.d. has made a total of 0 transactions in Millendo Therapeutics Inc (MLND) over the past 5 years. The most-recent trade in Millendo Therapeutics Inc is the acquisition of 14 shares on May 10, 2016, which cost Chapman Paul W.d. around $22,847.
Insider Trading History of Chapman Paul W.d.
- 1
Chapman Paul W.d. Trading Performance
GuruFocus tracks the stock performance after each of Chapman Paul W.d.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chapman Paul W.d. is -23.04%. GuruFocus also compares Chapman Paul W.d.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Chapman Paul W.d. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Chapman Paul W.d.'s insider trading performs compared to the benchmark.
Performance of Chapman Paul W.d.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -27.59 | | | | | |
| Relative Return to S&P 500(%) | -28.15 | | | | | |
Chapman Paul W.d. Ownership Network
Ownership Network List of Chapman Paul W.d.
Ownership Network Relation of Chapman Paul W.d.
Chapman Paul W.d. Owned Company Details
What does Millendo Therapeutics Inc do?
Who are the key executives at Millendo Therapeutics Inc?
Chapman Paul W.d. is the Chief Operating Officer of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include Chief Medical Officer Christophe Arbet-engels , Chief Development Officer Ryan Zeidan , and director & President and CEO Julia C. Owens .
Millendo Therapeutics Inc (MLND) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Millendo Therapeutics Inc Insider Transactions
Chapman Paul W.d. Mailing Address
Above is the net worth, insider trading, and ownership report for Chapman Paul W.d.. You might contact Chapman Paul W.d. via mailing address: 215 First Street, Suite 240, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
